Stock Smackdown: Cramer vs. CAPS

There's no denying that Mad Money host Jim Cramer is entertaining, popular, and passionate. On many occasions, he's even right. So he's smart, funny, and the closest thing to a stock market rock star -- but is he smarter than you?

Cramming for Cramer
The Fool's free investing community, Motley Fool CAPS, aggregates the opinions of more than 130,000 members to assign ratings for each stock's likelihood of outperforming or underperforming the market.

Below, we look at some top stocks that Cramer picked and panned during last week's "lightning rounds," and compare them to the CAPS community's opinions of their future.

Cramer says …
Even when everything's going your way, you shouldn't automatically expect even more good news on the horizon. Jim Cramer says that despite the news Hologic received from the FDA regarding its human papillomavirus assay, the women's health company still has to show that it will be able to perform in the wake of its recent acquisitions:

I feel like I have got burned in Hologic... I did not like that last acquisition, they had a history of making really good acquisitions... they came on the show all the time, I endorsed them... somebody screwed up, did Cramer screw up... I own it... I mean that I own the screw up... I do not own it... I feel like their whole logic is a Missouri situation... they have got to show us that they have the goods... I know that it just spiked on their news... but I need to see more than that... cause I liked it much, much higher.

CAPS says …
Yet investors remain inoculated against such gainsaying, based upon the deep bench of other potential heavy hitters in Hologic's arsenal. Just before the medical device company got the nod from the FDA, CAPS member Bamafan68 praised its commanding market share:

Hologic has a very healthy market share for women's care products, including ThinPrep pap smears and Novasure endometrial ablation devices which treats abnormal bleeding on an outpatient basis. With a HPV diagnostic test awaiting FDA approval and new HPV testing recommendations, I expect this company to grow.

Considering that Hologic's stock had been taken down earlier, alongside other medical device makers such as Intuitive Surgical (NASDAQ:ISRG) and Natus Medical, the company stands an excellent chance of a profitable recovery.

Your say
Whether CAPS members may stand with or against Jim Cramer, our investor-intelligence community is more than just the opinion of a handful of All-Stars -- even if they are TV personalities. What do you think? Is Cramer right or off his rocker? Head over to CAPS and sound off with your thoughts on Hologic or any of the stocks mentioned above.

Motley Fool CAPS is a great place to start your own investing research. Read a company's financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made, all from a stock's CAPS page. Best of all, it's free!